0001478242-24-000057.txt : 20240304
0001478242-24-000057.hdr.sgml : 20240304
20240304172714
ACCESSION NUMBER: 0001478242-24-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAUB W RICHARD
CENTRAL INDEX KEY: 0001181162
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 24716182
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 271341991
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2400 ELLIS ROAD
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 2400 ELLIS ROAD
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
wk-form4_1709591202.xml
FORM 4
X0508
4
2024-02-29
0
0001478242
IQVIA HOLDINGS INC.
IQV
0001181162
STAUB W RICHARD
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD
DURHAM
NC
27703
0
1
0
0
See Remarks
0
Common Stock
2024-02-29
4
S
0
8970
247.33
D
21075
D
Common Stock
2024-02-29
4
S
0
3062
248.33
D
18013
D
Common Stock
2024-02-29
4
S
0
2068
249.08
D
15945
D
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $246.84 to $247.83 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.84 to $248.82, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.84 to $249.47, inclusive.
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub
2024-03-04